Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Palisade Bio Inc (PALI)

Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Palisade Bio Inc 7750 El Camino Real Suite 2A Carlsbad CA 92009 USA

www.palisadebio.com Employees: 8 P: 858-704-4900

Sector:

Medical

Description:

Palisade Bio Inc. is a late-stage biopharma company advancing therapies which help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio Inc., formerly known as Seneca Biopharma Inc., is based in CARLSBAD, Calif.

Key Statistics

Overview:

Market Capitalization, $K 259,265
Enterprise Value, $K 249,525
Shares Outstanding, K 149,003
Float, K 148,929
% Float 99.95%
Short Interest, K 25,353
Short Float 17.02%
Days to Cover 8.00
Short Volume Ratio 0.27
% of Insider Shareholders 0.05%
% of Institutional Shareholders 11.79%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -14,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,870 K
EBIT, $ -11,450 K
EBITDA, $ -11,450 K

Growth:

1-Year Return 130.38%
3-Year Return -93.26%
5-Year Return -99.97%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 99.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.38 on 11/10/25
Next Earnings Date 03/23/26 [--]
Earnings Per Share ttm -2.12
EPS Growth vs. Prev Qtr 34.48%
EPS Growth vs. Prev Year 83.62%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 04/08/24

PALI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -240.81%
Return-on-Assets % -137.28%
Profit Margin % 0.00%
Debt/Equity 0.07
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 67.54
Book Value/Share 0.02
Interest Coverage -1,443.00
60-Month Beta 1.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar